Authors
Latest:
MPN-Associated Anemia: What Nurses Should Look Out ForOncology nurses should have open communication with patients and closely monitor their hemoglobin levels when dealing with patients with myelofibrosis who have or may have anemia.
Latest:
Rx Road Map: Subcutaneous Daratumumab in Multiple MyelomaA registered nurse gives best practices for use of subcutaneous daratumumab in multiple myeloma.
Latest:
Patient Experience Programs Improve Overall Quality of CarePatient experience programs can improve quality of care and decrease organization costs, resulting in a more efficient and less expensive cancer care journey for patients.
Latest:
Advice for New Nurse Practitioners Working With Patients With Endometrial CancerClosing their discussion, the panel shares advice for new nurse practitioners caring for patients who have endometrial cancer.
Latest:
Life After CAR T Therapy: Insights for Patients and Referring OncologistsThis video segment focuses on key elements of patient education and support for long-term CAR-T survivors, strategies to maintain quality of life and manage late effects, differences in supportive care needs between ide-cel and cilta-cel recipients, and approaches to fostering collaboration between academic centers and community practices for optimal long-term care.
Latest:
VCU Massey Cancer Center achieves comprehensive status from the National Cancer InstituteVCU Massey Cancer Center has been designated a Comprehensive Cancer Center by the National Cancer Institute (NCI), the nation’s principal authority on cancer research and training.
Latest:
Approvals in Cancer Care Call for Multidisciplinary CooperationWorking with multidisciplinary teams and educating patients are key to treating patients with cancer while navigating newly approved treatments.
Latest:
Innovative Program Reduces Nurse Turnover and Fosters DevelopmentThe US Oncology Network (The Network) has developed one of the most comprehensive programs in the nation to support the professional development and retention of new oncology nurses.
Latest:
CAR T-Cell Therapy May Be Moving Up in Myeloma Treatment SequencingCAR T-cell therapy is starting to enter treatment conversations sooner with patients with multiple myeloma, according to Nick Barkemeyer, PA-C, MMS.
Latest:
JSKN003 Shows Activity in Heavily Pretreated HER2+ Breast CancerPooled data from early-phase trials suggest JSKN003 is tolerable and active in patients with heavily pretreated HER2-positive disease.
Latest:
Adding Aprepitant to Chemo Extends Non-Luminal Breast Cancer SurvivalAdding aprepitant to chemotherapy was linked to longer survival in patients with non-luminal breast cancers, especially triple-negative breast cancer.
Latest:
Advice for New Nurse Practitioners Working With Patients With Endometrial CancerClosing their discussion, the panel shares advice for new nurse practitioners caring for patients who have endometrial cancer.
Latest:
Patient Education, Shared Decision-Making, and Optimizing Care for ESR1-Mutated Breast CancerPanelists discuss how a multidisciplinary team approach to patient education and medication management is crucial for ensuring adherence and optimal outcomes with oral medications like elacestrant.
Latest:
Recipe For DisasterAn oncology social worker reflects on a day in the life and how the memory of her sister motivates her to tackle her work.
Latest:
Psychological Concerns in the Aftermath of a Breast Cancer Diagnosis and Treatment for Young AdultsReceiving a breast cancer diagnosis and undergoing treatment as a young adult takes a physical and emotional toll.
Latest:
Oncology Nurses Can Help Better Prevent Chronic Lymphedema With BIS TechnologySheila Ridner, PhD, RN, FAAN, discusses the implications of the PREVENT study and how oncology nurses can advocate for patients with breast cancer.
Latest:
Cedars-Sinai Launches New Division of Population Sciences ResearchNew Division in the Department of Biomedical Sciences Conducts Translational Research and Engages With Community to Help Reduce the Burden of Disease and Improve Quality of Life.
Latest:
Recognition of the Advanced Practice Preceptor Role in OncologyA tiered level preceptor recognition program offers a cost-effective organizational intervention designed to acknowledge and incentivize the contributions of advanced practice preceptors.
Latest:
Elizabeth Loach on Integrating Frontline Staff in Nursing Task ForcesElizabeth Loach, MSN, APRN, CNS, AGCNS-BC, OCN, discusses the importance of including frontline nurses in nursing leadership task forces.
Latest:
Dispelling Nutrition Myths for Patients With CancerEntering the words nutrition and cancer into Google returns as many as 718 million hits. With an overabundance of opinions, it can be challenging to separate fact from fiction.
Latest:
How I Counsel Patients About Lung Cancer ScreeningA lung cancer screening navigator offers their perspective on shared decision-making.
Latest:
Nurses, APPs Lead as Sub-Investigators in Oncology Clinical TrialsAccording to a nurse practitioner who works in myeloma research, nurses and APPs are responsible for much of the clinical work with patients involved in trials.
Latest:
Facilitating End-of-Life Care for Patients With Breast CancerOncology nurses and APPs provide support and can help to facilitate conversations with patients and families during end-of-life care.
Latest:
Determining the Cause of Bicytopenia in a Patient With Progressive Dyspnea"Differential diagnoses in patients with bicytopenia—particularly those with preserved platelets—are broad and require careful physical examination."
Latest:
Expert Weighs in on Future of CAR T-Cell Therapy Treatment DirectionsKelly L. Garvin, BSN, RN, OCN, discusses what changes she hopes to see in CAR T-Cell therapy treatment over the coming years.
Latest:
“Be Part of the Revolution”: APPs as Primary Investigators in OncologyNurse practitioners and physician assistants can advocate to play a number of roles in oncology research, including primary investigators.
Latest:
Real-World Use of Ide-cel Provides Favorable Outcomes in CNS MyelomaPatients treated with ide-cel, Abecma for relapsed/refractory multiple myeloma affecting the central nervous system had similar outcomes to matched patients with non-CNS multiple myeloma.
Latest:
Darolutamide-ADT Combination Lengthens rPFS in mHSPC Regardless of Disease VolumePatients with metastatic hormone-sensitive prostate cancer experienced increase rPFS and other efficacy end points with darolutamide plus ADT.
Latest:
How I Counsel Patients About Lung Cancer ScreeningA lung cancer screening navigator offers their perspective on shared decision-making.
Latest:
Routine Helps Patients With Breast Cancer on CDK4/6 Inhibitors Gain IndependenceEstablishing a routine early in treatment helps proactively manage adverse effects associated with CDK4/6 inhibitors, says Kimberly Podsada, BSN, RN, MSN, NP-C, CNS.
